ATLANTA--(BUSINESS WIRE)--Nov. 30, 2005--Serologicals Corporation (NASDAQ:SERO), announced today that the United States Patent and Trademark Office awarded, on November 15, 2005, patent no. 6,964,951 with respect to its recently acquired ubiquitous chromatin opening element (UCOE) technology.
